Prosecution Insights
Prosecution Insights
60 pending office actions • 36 art units • 56 examiners • 0 of 60 (0%) have an AI response strategy ready • 54 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 20 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 20 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 3 (5%) |
| §103 only | 14 (23%) |
| §102 only | 2 (3%) |
| §112 only | 5 (8%) |
| Double-patenting only | 6 (10%) |
| Double-patenting + other | 6 (10%) |
| Multi-statute (no §101) | 23 (38%) |
| No statute on record | 1 (2%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SCHMITT, MICHAEL J | 2 | 56.6% | +21.7% |
| RAMIREZ, DELIA M | 2 | 65.1% | +56.3% |
| FLINDERS, JEREMY C | 2 | 63.7% | +16.7% |
| MOLOYE, TITILAYO | 2 | 63.1% | +47.1% |
| MOSS, JAMES R | 1 | 51.1% | +40.7% |
| SUO, JOSHUA JUNGWOOK | 1 | 70.0% | +33.3% |
| LI, WENHAN | 1 | — | — |
| YENTRAPATI, AVINASH | 1 | 74.9% | -4.7% |
| WHITE, DAWANNA SHAR-DAY | 1 | 62.3% | +20.3% |
| BRAZIN, JACQUELINE | 1 | 66.2% | +52.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18266917 | USE OF MGLUR5 ANTAGONISTS FOR TREATING GAMBLING DISORDER | ROZOF, TIMOTHY R | 49d overdue |
| 18003125 | Compositions and Methods for Selective Detection and/or Inhibition of Bacterial Pathogens in Microbial Communities | BREEN, KIMBERLY CATHERINE | 10d overdue |
| 18790607 | Protein Capture Membrane and Method of Use Thereof | BRAZIN, JACQUELINE | 9d overdue |
| 18042993 | Compounds and Compositions for Disrupting Programmed Ribosomal Frameshifting | KIM, SEONG JONG | 4d overdue |
| 18002710 | PanK Modulators and Methods Using Same | VISHNYAKOVA, ELENA VLADIMIROVNA | 40d |
| 18623722 | EGFR PROTEOLYSIS TARGETING CHIMERIC MOLECULES AND ASSOCIATED METHODS OF USE | DAHLIN, HEATHER RAQUEL | 53d |
| 18856787 | NANOPARTICLES AND NANOPARTICLE-RELEASING VAGINAL RINGS | LI, WENHAN | — |
| 18843593 | AUTOMATED TEST OF EMBODIED COGNITION | YENTRAPATI, AVINASH | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17845461 | COMPOSITION AND METHODS FOR CULTURING RETINAL PROGENITOR CELLS | MOLOYE, TITILAYO | 36d overdue |
| 17764804 | DETERMINISTIC BARCODING FOR SPATIAL OMICS SEQUENCING | FLINDERS, JEREMY C | 28d overdue |
| 18790607 | Protein Capture Membrane and Method of Use Thereof | BRAZIN, JACQUELINE | 9d overdue |
| 18446296 | Bi-functional Molecules To Degrade Circulating Proteins | SCHMITT, MICHAEL J | 14d |
| 17756212 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING ISCHEMIA-REPERFUSION INJURY AND/OR LUNG INJURY | SCHMITT, MICHAEL J | 20d |
| 19077565 | INTRACARDIAC DEVICE | MOSS, JAMES R | — |
| 18987814 | METHODS OF INCORPORATING SPORADIC OBJECTS ONTO AN EXISTING MESH | SUO, JOSHUA JUNGWOOK | — |
| 18840040 | METHODS OF TREATING, AMELIORATING, OR PREVENTING HEART FAILURE, AND METHODS OF PROMOTING HEART MUSCLE GROWTH | WHITE, DAWANNA SHAR-DAY | — |
| Art Unit | Apps |
|---|---|
| 1684 | 4 |
| 1629 | 3 |
| 1625 | 3 |
| 1632 | 3 |
| 1612 | 2 |
| 1655 | 2 |
| 1622 | 2 |
| 3791 | 2 |
| 1644 | 2 |
| 1652 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19077565 | INTRACARDIAC DEVICE | MOSS, JAMES R | — | DP | Non-Final OA | — | Pending | Mar 12, 2025 |
| 18987814 | METHODS OF INCORPORATING SPORADIC OBJECTS ONTO AN EXISTING MESH | SUO, JOSHUA JUNGWOOK | — | §103 | Non-Final OA | — | Pending | Dec 19, 2024 |
| 18856787 | NANOPARTICLES AND NANOPARTICLE-RELEASING VAGINAL RINGS | LI, WENHAN | — | §102§103 | Non-Final OA | — | Pending | Oct 14, 2024 |
| 18843593 | AUTOMATED TEST OF EMBODIED COGNITION | YENTRAPATI, AVINASH | — | §101§102§103§112 | Non-Final OA | — | Pending | Sep 03, 2024 |
| 18840040 | METHODS OF TREATING, AMELIORATING, OR PREVENTING HEART FAILURE, AND METHODS OF PROMOTING HEART MUSCLE GROWTH | WHITE, DAWANNA SHAR-DAY | — | §102§103§112 | Non-Final OA | — | Pending | Aug 20, 2024 |
| 18790607 | Protein Capture Membrane and Method of Use Thereof | BRAZIN, JACQUELINE | 1798 | §102§103 | Non-Final OA | 9d overdue | Pending | Jul 31, 2024 |
| 18724520 | METHODS OF TREATING, AMELIORATING, AND/OR PREVENTING STRESS-RELATED DISORDER | CORNET, JEAN P | — | §103§112 | Non-Final OA | — | Pending | Jun 26, 2024 |
| 18674209 | POLY(AMINE-CO-ESTER) POLYMERS AND POLYPLEXES WITH MODIFIED END GROUPS AND METHODS OF USE THEREOF | COHEN, MICHAEL P | 1612 | §102Other | Non-Final OA | 16d | Pending | May 24, 2024 |
| 18653162 | Bioprinting of Collagenous Bioinks | SWANSON, ANDREW L | 1745 | §102§103§112 | Final Rejection | — | Pending | May 02, 2024 |
| 18648749 | METHODS, SYSTEMS AND COMPOSITIONS FOR NORMOTHERMIC EX VIVO PRESERVATION OF INTACT ORGANS | KOSAR, AARON J | 1655 | DP | Non-Final OA | — | Pending | Apr 29, 2024 |
| 18701027 | IMPROVED SELECTIVE JAK2 INHIBITORS AND METHODS OF USE | VAJDA, KRISTIN ANN | 1622 | DP | Non-Final OA | — | Pending | Apr 12, 2024 |
| 18623722 | EGFR PROTEOLYSIS TARGETING CHIMERIC MOLECULES AND ASSOCIATED METHODS OF USE | DAHLIN, HEATHER RAQUEL | 1629 | §103§112Other | Non-Final OA | 53d | Pending | Apr 01, 2024 |
| 18616372 | ENDOBRONCHIAL BLOCKER SYSTEM AND APPARATUS | HOAG, MITCHELL BRAIN | 3771 | §103 | Final Rejection | 23d | Pending | Mar 26, 2024 |
| 18692729 | NANOPARTICLE SURFACE TOPOGRAPHY MODIFIED WITH BOTTLEBRUSH BLOCK COPOLYMERS | ABBAS, ABDULRAHMAN MUSTAFA | 1612 | §103 | Non-Final OA | — | Pending | Mar 15, 2024 |
| 18690785 | METHODS, SYSTEMS AND COMPOSITIONS FOR RESTORATION AND PRESERVATION OF INTACT ORGANS IN A MAMMAL | YOH, JULIUS FRANCIS | 1633 | DP | Non-Final OA | — | Pending | Mar 11, 2024 |
| 18684124 | COMPOSITIONS AND METHODS FOR GENERATING TICK IMMUNITY | GRASER, JENNIFER E | 1645 | §101§102§103§112DP | Non-Final OA | — | Pending | Feb 15, 2024 |
| 18558943 | SEQUENCE-DEFINED POLYMERS WITH ONE OR MORE AZIDES, METHODS OF MAKING, AND METHODS OF USE THEREOF | SPANGLER, JOSEPH RANKIN | 1656 | §103§112 | Non-Final OA | — | Pending | Nov 03, 2023 |
| 18486265 | DEVICE, SYSTEM AND METHOD FOR CONTINUOUS ESTIMATION OF ORGAN AND TISSUE SIZE AND CONTENT WITHIN AN INTACT ORGANISM | YOON, CHANEL J | 3791 | §103§112 | Non-Final OA | — | Pending | Oct 13, 2023 |
| 18282206 | SYSTEMS AND METHODS FOR DETERMINING BARCODES AND SCREENING IN SITU | BUNKER, AMY M | 1684 | §102§103§112 | Non-Final OA | — | Pending | Sep 14, 2023 |
| 18548823 | Compositions and Methods for Treating Skeletal Muscle Disease | JOHANSEN, PETER N. | 1644 | §102§103§112 | Non-Final OA | — | Pending | Sep 01, 2023 |
| 18277505 | MULTIMODE SUPERCONDUCTING CAVITY RESONATORS | HOSSAIN, MOAZZAM | 2898 | §103 | Non-Final OA | 15d | Pending | Aug 16, 2023 |
| 18446296 | Bi-functional Molecules To Degrade Circulating Proteins | SCHMITT, MICHAEL J | 1629 | Other | Non-Final OA | 14d | Pending | Aug 08, 2023 |
| 18354428 | COMPOSITIONS AND METHODS FOR TREATING, AMELIORATING, AND/OR PREVENTING DISEASES OR DISORDERS CAUSED BY OR ASSOCIATED WITH DNASE1 AND/OR DNASE1L3 DEFICIENCY | RAMIREZ, DELIA M | 1652 | §103§112Other | Final Rejection | — | Pending | Jul 18, 2023 |
| 18270684 | HIGH-SPATIAL-RESOLUTION EPIGENOMIC PROFILING | KAPUSHOC, STEPHEN THOMAS | 1683 | §103§112DP | Non-Final OA | — | Pending | Jun 30, 2023 |
| 18266917 | USE OF MGLUR5 ANTAGONISTS FOR TREATING GAMBLING DISORDER | ROZOF, TIMOTHY R | 1625 | §103§112 | Final Rejection | 49d overdue | Pending | Jun 13, 2023 |
| 18253250 | TARGETING HOST-BACTERIA INTERACTIONS FOR THE TREATMENT OF MICROBIOTA-MEDIATED DISEASES | GROSS, CHRISTOPHER M | 1684 | §102§112 | Non-Final OA | — | Pending | May 17, 2023 |
| 18317526 | Rapidly synthesized extracellular matrix-based gels and patterning techniques, from micro- to macro-scale | PAULUS, ERIN VIRGINIA | 1631 | §102§103§112 | Non-Final OA | — | Pending | May 15, 2023 |
| 18312793 | SYSTEM AND METHOD FOR REMOVING CARBON DIOXIDE FROM SEA WATER | KEYWORTH, PETER | 1777 | §112 | Non-Final OA | — | Pending | May 05, 2023 |
| 18299324 | Reverse Transcriptase and Methods of Use | KANE, TREVOR LOGAN | 1657 | DP | Final Rejection | — | Pending | Apr 12, 2023 |
| 18295446 | ALL-OPTICAL VISUALIZATION OF SPECIFIC MOLECULES IN THE ULTRASTRUCTURAL CONTEXT OF BRAIN TISSUE | DOWNES, NATHANAEL JASON | — | §102§103 | Non-Final OA | — | Pending | Apr 04, 2023 |
| 18042993 | Compounds and Compositions for Disrupting Programmed Ribosomal Frameshifting | KIM, SEONG JONG | 1621 | §103§112 | Non-Final OA | 4d overdue | Pending | Feb 24, 2023 |
| 18042385 | Nanobody Compositions and Methods of Use of the Same | FLINDERS, JEREMY C | 1684 | §101§102§112DP | Non-Final OA | — | Pending | Feb 21, 2023 |
| 18041504 | COMPOSITIONS AND METHODS FOR ENGINEERING AND SELECTION OF CAR T CELLS WITH DESIRED PHENOTYPES | GROOMS, TIFFANY NICOLE | 1637 | §103 | Non-Final OA | — | Pending | Feb 13, 2023 |
| 18161712 | Bifunctional Small Molecules to Target the Selective Degradation of Circulating Proteins | LEE, JIA-HAI | 1658 | §103DPOther | Non-Final OA | — | Pending | Jan 30, 2023 |
| 18006590 | RAPID CLINICAL TEST FOR GENETIC DIAGNOSIS INVOLVING KNOWN VARIANTS | BAUSCH, SARAE L | 1699 | §102§103 | Non-Final OA | — | Pending | Jan 24, 2023 |
| 18003125 | Compositions and Methods for Selective Detection and/or Inhibition of Bacterial Pathogens in Microbial Communities | BREEN, KIMBERLY CATHERINE | 1657 | §103§112 | Final Rejection | 10d overdue | Pending | Dec 22, 2022 |
| 18002710 | PanK Modulators and Methods Using Same | VISHNYAKOVA, ELENA VLADIMIROVNA | 1691 | §102§103§112Other | Non-Final OA | 40d | Pending | Dec 21, 2022 |
| 18002477 | Methods of Treating, Ameliorating, Shortening Duration, and/or Reversing Symptoms and/or Complications of a Coronavirus Infection | RZECZYCKI, PHILLIP MATTHEW | 1625 | §103 | Final Rejection | 29d | Pending | Dec 19, 2022 |
| 18000957 | COMPOSITIONS AND METHODS FOR TREATING AND/OR PREVENTING COAGULOPATHY AND/OR SEPSIS IN PATIENTS SUFFERING FROM BACTERIAL AND/OR VIRAL INFECTIONS | MOLOYE, TITILAYO | 1632 | §103DP | Final Rejection | — | Pending | Dec 07, 2022 |
| 18073852 | DRUG THERAPY TO INHIBIT CHEMOTHERAPY-INDUCED ADVERSE EFFECTS AND RELATED PHARMACEUTICAL COMPOSITIONS, DIAGNOSTICS, SCREENING TECHNIQUES AND KITS | NGUYEN, JOHN P | 1619 | §103 | Non-Final OA | — | Pending | Dec 02, 2022 |
| 17928381 | STABLE PEPTIDES HAVING RENALASE AGONIST ACTIVITY | KATAKAM, SUDHAKAR | 1658 | §112 | Non-Final OA | — | Pending | Nov 29, 2022 |
| 17999324 | AN INTEGRATED DIELECTROPHORESIS-TRAPPING AND NANOWELL TRANSFER APPROACH TO ENABLE DOUBLE-SUB-POISSON SINGLE-CELL RNA-SEQUENCING | CHUNDURU, SURYAPRABHA | 1681 | §103 | Non-Final OA | 9d overdue | Pending | Nov 18, 2022 |
| 17822332 | TARGETED MEASURE OF TRANSCRIPTIONAL ACTIVITY RELATED TO HORMONE RECEPTORS | JOHANNSEN, DIANA B | 1682 | DP | Final Rejection | — | Pending | Aug 25, 2022 |
| 17801486 | TREATMENT FOR CHEMOBRAIN | ABDALHAMEED, MANAHIL MIRGHANI ALI | 1622 | §103 | Final Rejection | — | Pending | Aug 22, 2022 |
| 17813395 | INTEGRATED CIRCUIT WITH TOPOLOGICAL SEMIMETAL INTERCONNECTS | DUMBRIS, SETH M | 1784 | §103 | Final Rejection | 34d | Pending | Jul 19, 2022 |
| 17792101 | COMPOSITIONS AND METHODS FOR TREATING, AMELIORATING, AND/OR PREVENTING DISEASES OR DISORDERS CAUSED BY OR ASSOCIATED WITH DNASE1 AND/OR DNASE1L3 DEFICIENCY | RAMIREZ, DELIA M | 1652 | §102§103 | Final Rejection | — | Pending | Jul 11, 2022 |
| 17845461 | COMPOSITION AND METHODS FOR CULTURING RETINAL PROGENITOR CELLS | MOLOYE, TITILAYO | 1632 | §103 | Final Rejection | 36d overdue | Pending | Jun 21, 2022 |
| 17782914 | COMPOSITIONS AND METHODS FOR PREVENTING RECURRENCE OF CANCER | BOECKELMAN, JACOB A | 1655 | §102DP | Final Rejection | — | Pending | Jun 06, 2022 |
| 17756212 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING ISCHEMIA-REPERFUSION INJURY AND/OR LUNG INJURY | SCHMITT, MICHAEL J | 1629 | §102Other | Non-Final OA | 20d | Pending | May 19, 2022 |
| 17776922 | METHODS OF INDUCING OR ENHANCING FARNESOID X RECEPTOR (FXR)-MEDIATED TRANSCRIPTIONAL RESPONSE | CHANDRAKUMAR, NIZAL S | 1625 | §103 | Final Rejection | — | Pending | May 13, 2022 |
| 17769642 | COMPOSITIONS AND METHODS FOR INHIBITION OF CELL-PENETRATING ANTIBODIES | PATTERSON, SARAH COOPER | 1675 | §112 | Non-Final OA | 11d overdue | Pending | Apr 15, 2022 |
| 17768145 | ENGINEERED ANTIBODIES AS MOLECULAR DEGRADERS THROUGH CELLULAR RECEPTORS | HIBSHMAN, SARAH GRACE | 1693 | §103§112DP | Final Rejection | 70d overdue | Pending | Apr 11, 2022 |
| 17764804 | DETERMINISTIC BARCODING FOR SPATIAL OMICS SEQUENCING | FLINDERS, JEREMY C | 1684 | §103Other | Final Rejection | 28d overdue | Pending | Mar 29, 2022 |
| 17637100 | PORTABLE AND COMPACT SYSTEM FOR DELIVERY OF HUMIDIFIED HIGH FLOW NASAL CANNULA (HHFNC) THERAPY IN NEONATES AND INFANTS | KHONG, BRIAN THAI-BINH | 3700 | §112 | Final Rejection | — | Pending | Feb 22, 2022 |
| 17626903 | Genetically Modified Non-Human Animals and Methods of Use Thereof | SINGH, ANOOP KUMAR | 1632 | §103§112 | Non-Final OA | — | Pending | Jan 13, 2022 |
| 17625683 | COMPOSITIONS AND METHODS OF USING A HUMANIZED ANTI-DKK2 ANTIBODY | PETRASH, HILARY ANN | 1644 | §102§112DP | Final Rejection | — | Pending | Jan 07, 2022 |
| 17312260 | MICROBIOTA METABOLITES THAT SHAPE HOST PHYSIOLOGY | MEYERING, SHABANA SHABBEER | 1600 | §103§112 | Non-Final OA | — | Pending | Jun 09, 2021 |
| 17283315 | Selective Binding and Aggregation of Human Keratin in the Skin Barrier Using Human Filaggrin Subdomains SD67 and SD150 | DABKOWSKI, ERINNE R | 1654 | §112 | Final Rejection | 57d | Pending | Apr 07, 2021 |
| 17223551 | COMPOUNDS AND METHODS FOR TARGETED DEGRADATION OF KRAS | MCMILLIAN, KARA RENITA | 1623 | §102§103Other | Non-Final OA | — | Pending | Apr 06, 2021 |
| 15548197 | INTEGRATED PAINLESS BONE MARROW BIOPSY DEVICE | CATINA, MICHAEL ANTHONY | 3791 | §103 | Final Rejection | 30d | Pending | Aug 02, 2017 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial